Lista de obras -

Advances in development of countermeasures for potential biothreat agents.

artículo científico publicado en 2012

Aluminum-containing vaccine associated adverse events: role of route of administration and gender

scientific article published on 01 May 2002

An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland

artículo científico publicado en 2005

Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome.

artículo científico publicado en 2008

Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.

artículo científico publicado en 2014

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

scientific article published on 01 September 2000

Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination

artículo científico publicado en 2006

Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity

artículo científico publicado en 2013

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

artículo científico publicado en 2008

Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

artículo científico publicado en 2014

Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood

artículo científico publicado en 2016

Immune interference after sequential alphavirus vaccine vaccinations

scientific article published on 11 March 2009

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

artículo científico publicado en 2011

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

artículo científico publicado en 1999

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

artículo científico publicado en 1998

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

artículo científico publicado en 1996

Long-term health effects of repeated exposure to multiple vaccines

scientific article published on 01 December 2004

Management guidelines for laboratory exposures to agents of bioterrorism

scientific article published on 01 August 2004

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

artículo científico publicado en 2006

Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.

artículo científico publicado en 2006

Povidone Iodine Ointment Application to the Vaccination Site Does Not Alter Immunoglobulin G Antibody Response to Smallpox Vaccine.

artículo científico publicado en 2016

Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.

artículo científico publicado en 2005

Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.

artículo científico publicado en 2015

Rudolf Hess - The Doppelgänger conspiracy theory disproved

scientific article published on 11 January 2019

Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.

artículo científico publicado en 2015

Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.

artículo científico publicado en 2015

Transcriptional profiling of recall responses to Francisella live vaccine strain.

artículo científico publicado en 2014

Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination

artículo científico publicado en 2007

Lista de obras de

Advances in development of countermeasures for potential biothreat agents.

Aluminum-containing vaccine associated adverse events: role of route of administration and gender

An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland

Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome.

Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination

Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood

Immune interference after sequential alphavirus vaccine vaccinations

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

Long-term health effects of repeated exposure to multiple vaccines

Management guidelines for laboratory exposures to agents of bioterrorism

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.

Povidone Iodine Ointment Application to the Vaccination Site Does Not Alter Immunoglobulin G Antibody Response to Smallpox Vaccine.

Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.

Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.

Rudolf Hess - The Doppelgänger conspiracy theory disproved

Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.

Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.

Transcriptional profiling of recall responses to Francisella live vaccine strain.

Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination